FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891269937> ?p ?o ?g. }

• W2891269937 endingPage "9" @default.
• W2891269937 startingPage "1" @default.
• W2891269937 abstract "The low aqueous solubility of diazepam (DZP) presents a challenge in formulating nasal sprays without the use of organic solvents. One approach to overcome this challenge involves co-administration of a soluble prodrug, avizafone (AVF), with a converting enzyme to produce supersaturated DZP at the site of administration. In addition to overcoming solubility issues, the supersaturated state of DZP provides an increased driving force for enhanced permeation across nasal mucosa. However, supersaturated solutions are metastable, and there is a limit to the degree of supersaturation (S) that can be reached without causing spontaneous phase separation of the solute. The aim of this article was to determine how formulation parameters affect the rate of DZP supersaturation, maximum degree of supersaturation, and phase separation kinetics. A model enzyme, Aspergillus oryzae protease (AOP), was used to convert AVF to DZP, via an open ring intermediate (ORI). A second derivative UV spectroscopic method was developed to simultaneously monitor DZP solution concentration and the time course of DZP phase separation. Fitting a kinetic model, with prior knowledge of the enzyme kinetic parameters, the rate constant for conversion of ORI to DZP was found to be 0.470 ± 0.012 min−1. Kinetics and supersaturated solution stability were studied as a function of formulation parameters, including temperature, pH, buffering agent, AVF concentration, and enzyme concentration. The maximum aqueous solution concentration for DZP at 32 °C was determined to be 1.22 ± 0.03 mM DZP (S = 9.38) and was insensitive to changes in formulation parameters, excepting temperature. Supersaturated solutions of DZP could be maintained at the maximum concentration for >24 h, even in the presence of phase separated DZP. Polarized light microscopy, PXRD, and DSC analysis indicated that the phase separated DZP was amorphous upon formation and remained so for >24 h. Our findings suggest that co-administration of AVF with a suitable human converting enzyme will provide a viable mechanism for IN delivery of DZP and result in very rapid and complete absorption to quickly terminate seizure emergencies." @default.
• W2891269937 created "2018-09-27" @default.
• W2891269937 creator A5017431830 @default.
• W2891269937 creator A5032842851 @default.
• W2891269937 creator A5089845134 @default.
• W2891269937 date "2018-11-01" @default.
• W2891269937 modified "2023-09-29" @default.
• W2891269937 title "Conversion of a soluble diazepam prodrug to supersaturated diazepam for rapid intranasal delivery: Kinetics and stability" @default.
• W2891269937 cites W1824385695 @default.
• W2891269937 cites W1831319345 @default.
• W2891269937 cites W1972667216 @default.
• W2891269937 cites W1974183245 @default.
• W2891269937 cites W1984799539 @default.
• W2891269937 cites W1996281261 @default.
• W2891269937 cites W1996553985 @default.
• W2891269937 cites W2004091098 @default.
• W2891269937 cites W2006845191 @default.
• W2891269937 cites W2009867031 @default.
• W2891269937 cites W2018340655 @default.
• W2891269937 cites W2024816431 @default.
• W2891269937 cites W2025892436 @default.
• W2891269937 cites W2041145659 @default.
• W2891269937 cites W2047978949 @default.
• W2891269937 cites W2072724200 @default.
• W2891269937 cites W2073616720 @default.
• W2891269937 cites W2085107912 @default.
• W2891269937 cites W2103113129 @default.
• W2891269937 cites W2130067639 @default.
• W2891269937 cites W2168901639 @default.
• W2891269937 cites W2243158166 @default.
• W2891269937 cites W2315526175 @default.
• W2891269937 cites W2320089805 @default.
• W2891269937 cites W2320607110 @default.
• W2891269937 cites W2342682435 @default.
• W2891269937 cites W2394803070 @default.
• W2891269937 cites W2460146977 @default.
• W2891269937 cites W2465853398 @default.
• W2891269937 cites W2770541662 @default.
• W2891269937 doi "https://doi.org/10.1016/j.jconrel.2018.09.013" @default.
• W2891269937 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30227158" @default.
• W2891269937 hasPublicationYear "2018" @default.
• W2891269937 type Work @default.
• W2891269937 sameAs 2891269937 @default.
• W2891269937 citedByCount "8" @default.
• W2891269937 countsByYear W28912699372019 @default.
• W2891269937 countsByYear W28912699372020 @default.
• W2891269937 countsByYear W28912699372021 @default.
• W2891269937 countsByYear W28912699372022 @default.
• W2891269937 countsByYear W28912699372023 @default.
• W2891269937 crossrefType "journal-article" @default.
• W2891269937 hasAuthorship W2891269937A5017431830 @default.
• W2891269937 hasAuthorship W2891269937A5032842851 @default.
• W2891269937 hasAuthorship W2891269937A5089845134 @default.
• W2891269937 hasConcept C108215921 @default.
• W2891269937 hasConcept C121332964 @default.
• W2891269937 hasConcept C148898269 @default.
• W2891269937 hasConcept C155574463 @default.
• W2891269937 hasConcept C178790620 @default.
• W2891269937 hasConcept C184651966 @default.
• W2891269937 hasConcept C185592680 @default.
• W2891269937 hasConcept C200447597 @default.
• W2891269937 hasConcept C43617362 @default.
• W2891269937 hasConcept C44280652 @default.
• W2891269937 hasConcept C55493867 @default.
• W2891269937 hasConcept C62520636 @default.
• W2891269937 hasConcept C71924100 @default.
• W2891269937 hasConcept C85663871 @default.
• W2891269937 hasConcept C98274493 @default.
• W2891269937 hasConceptScore W2891269937C108215921 @default.
• W2891269937 hasConceptScore W2891269937C121332964 @default.
• W2891269937 hasConceptScore W2891269937C148898269 @default.
• W2891269937 hasConceptScore W2891269937C155574463 @default.
• W2891269937 hasConceptScore W2891269937C178790620 @default.
• W2891269937 hasConceptScore W2891269937C184651966 @default.
• W2891269937 hasConceptScore W2891269937C185592680 @default.
• W2891269937 hasConceptScore W2891269937C200447597 @default.
• W2891269937 hasConceptScore W2891269937C43617362 @default.
• W2891269937 hasConceptScore W2891269937C44280652 @default.
• W2891269937 hasConceptScore W2891269937C55493867 @default.
• W2891269937 hasConceptScore W2891269937C62520636 @default.
• W2891269937 hasConceptScore W2891269937C71924100 @default.
• W2891269937 hasConceptScore W2891269937C85663871 @default.
• W2891269937 hasConceptScore W2891269937C98274493 @default.
• W2891269937 hasFunder F4320306684 @default.
• W2891269937 hasFunder F4320308528 @default.
• W2891269937 hasLocation W28912699371 @default.
• W2891269937 hasLocation W28912699372 @default.
• W2891269937 hasOpenAccess W2891269937 @default.
• W2891269937 hasPrimaryLocation W28912699371 @default.
• W2891269937 hasRelatedWork W2030128944 @default.
• W2891269937 hasRelatedWork W2049679044 @default.
• W2891269937 hasRelatedWork W2062879736 @default.
• W2891269937 hasRelatedWork W2066372970 @default.
• W2891269937 hasRelatedWork W2079498659 @default.
• W2891269937 hasRelatedWork W2086630193 @default.
• W2891269937 hasRelatedWork W2088753015 @default.
• W2891269937 hasRelatedWork W2556496813 @default.
• W2891269937 hasRelatedWork W2794132815 @default.

• next